Researcher
Raf Van Campenhout
- Keywords:Pharmacy and pharmacology
- Disciplines:Cell signalling, Other (bio)medical engineering not elsewhere classified, Hepatology, Toxicology and toxinology not elsewhere classified, Pharmacology not elsewhere classified
Affiliations
- Faculty of Medicine and Pharmacy (Faculty)
Member
From6 Jul 2018 → Today - Experimental in vitro toxicology and dermato-cosmetology (Research group)
Member
From23 Sep 2016 → Today - Pharmaceutical and Pharmacological Sciences (Department)
Member
From1 Jan 2023 → Today - Pharmaceutical and Pharmacological Sciences (Department)
Member
From8 Apr 2019 → 31 Dec 2022 - Pharmaceutical and Pharmacological Sciences (Department)
Member
From1 Oct 2018 → 20 Oct 2022 - Pharmaceutical and Pharmacological Sciences (Department)
Member
From1 Oct 2018 → 9 Sep 2018 - Faculty of Medicine and Pharmacy (Faculty)
Member
From23 Sep 2016 → 27 Jun 2018
Publications
1 - 10 of 15
- Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury(2023)
Authors: Raf Van Campenhout, Timo W M De Groof, Prashant Kadam, Brenda R. Kwak, Serge Muyldermans, Nick Devoogdt, Mathieu Vinken
Pages: 371 - Pannexin1 channels in the liver: an open enemy.(2023)
Authors: Raf Van Campenhout, Anne Caufriez, Andres Tabernilla Garcia, Amy Maerten, Sybren De Boever, Julen Sanz-Serrano, Prashant Kadam, Mathieu Vinken
- Effects of acute and chronic disease on cell junctions in mouse liver(2023)
Authors: Raf Van Campenhout, Bruno Cogliati, Mathieu Vinken
- Effects of drugs formerly suggested for COVID-19 repurposing on pannexin1 channels.(2022)
Authors: Anne Caufriez, Andres Tabernilla Garcia, Raf Van Campenhout, Axelle Cooreman, Kaat Leroy, Julen Sanz-Serrano, Prashant Kadam, Bruna dos Santos Rodrigues, Arthur Lamouroux, Steven Ballet, et al.
- Effects of drugs formerly proposed for COVID-19 treatment on connexin43 hemichannels.(2022)
Authors: Axelle Cooreman, Anne Caufriez, Andres Tabernilla Garcia, Raf Van Campenhout, Kaat Leroy, Prashant Kadam, Julen Sanz-Serrano, Bruna dos Santos Rodrigues, Pieter Annaert, Mathieu Vinken
- Expression and functionality of connexin-based channels in human liver cancer cell lines(2021)
Authors: Kaat Leroy, Cícero Júlio Silva Costa, Alanah Pieters, Bruna dos Santos Rodrigues, Raf Van Campenhout, Axelle Cooreman, Andres Tabernilla Garcia, Bruno Cogliati, Mathieu Vinken
- Connexin-based channel activity is not specifically altered by hepatocarcinogenic chemicals(2021)
Authors: Kaat Leroy, Alanah Pieters, Axelle Cooreman, Raf Van Campenhout, Bruno Cogliati, Mathieu Vinken
- In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach(2021)
Authors: Andres Tabernilla Garcia, Bruna dos Santos Rodrigues, Alanah Pieters, Anne Caufriez, Kaat Leroy, Raf Van Campenhout, Axelle Cooreman, Ana Rita Coelho Gomes, Emma Gustafson, Eva Gijbels, et al.
Pages: 1-45 - Mechanisms underlying connexin hemichannel activation in disease(2021)
Authors: Raf Van Campenhout, Ana Rita Coelho Gomes, Timo W M De Groof, Serge Muyldermans, Nick Devoogdt, Mathieu Vinken
Pages: 1-13 - Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor(2021)
Authors: Raf Van Campenhout, Serge Muyldermans, Mathieu Vinken, Nick Devoogdt, Timo W M De Groof
Pages: 1-19